Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development

被引:14
作者
Islam, Rumana [1 ]
Lane, Sheila [2 ]
Williams, Suzannah A. [3 ]
Becker, Christian M. [4 ]
Conway, Gerard S. [5 ]
Creighton, Sarah M. [6 ]
机构
[1] Oxford Univ Hosp, John Radcliffe Hosp, Dept Reprod Med, Oxford, England
[2] Oxford Univ Hosp, John Radcliffe Hosp, Dept Paediat Oncol & Haematol, Oxford, England
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Womens & Reprod Hlth, Womens Ctr, Oxford, England
[4] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, John Radcliffe Hosp, Womens Ctr,Oxford Endometriosis CaRe Ctr, Oxford, England
[5] Univ Coll London Hosp, Dept Endocrinol, London, England
[6] Univ Coll London Hosp, Elizabeth Garrett Anderson UCL Inst Womens Hlth, London, England
关键词
androgen insensitivity syndrome; androgen synthesis defects; differences in sex development; fertility preservation; in vitro maturation; testicular tissue cryopreservation; spermatogonial cells; ANDROGEN INSENSITIVITY SYNDROME; SPERMATOGONIAL STEM-CELLS; TESTICULAR TISSUE CRYOPRESERVATION; IN-VITRO DIFFERENTIATION; MALE PSEUDOHERMAPHRODITISM; 5-ALPHA-REDUCTASE-2; DEFICIENCY; OVARIAN TISSUE; GERM-CELLS; 46; XY DISORDERS; GENE-EXPRESSION;
D O I
10.1111/cen.13994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDiscordance between gonadal type and gender identity has often led to an assumption of infertility in patients with differences in sex development (DSD). However, there is now greater recognition of fertility being an important issue for this group of patients. Currently, gonadal tissue that may have fertility potential is not being stored for individuals with DSD and, where gonadectomy forms part of management, is often discarded. The area of fertility preservation has been predominantly driven by oncofertility which is a field dedicated to preserving the fertility of patients undergoing gonadotoxic cancer treatment. The use of fertility preservation techniques could be expanded to include individuals with DSD where functioning gonads are present. MethodsThis is a systematic literature review evaluating original research articles and relevant reviews between 1974 and 2018 addressing DSD and fertility, in vitro maturation of sperm, and histological/ultrastructural assessment of gonadal tissue in complete and partial androgen insensitivity syndrome, 17 beta-hydroxysteroid dehydrogenase type 3 and 5 alpha-reductase deficiency. ConclusionSuccessful clinical outcomes of ovarian tissue cryopreservation are paving the way for similar research being conducted using testicular tissue and sperm. There have been promising results from both animal and human studies leading to cryopreservation of testicular tissue now being offered to boys prior to cancer treatment. Although data are limited, there is evidence to suggest the presence of reproductive potential in the gonads of some individuals with DSD. Larger, more detailed studies are required, but if these continue to be encouraging, individuals with DSD should be given the same information, opportunities and access to fertility preservation as other patient groups.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 84 条
  • [1] Development of Postmeiotic Cells In Vitro from Spermatogonial Cells of Prepubertal Cancer Patients
    Abofoul-Azab, Maram
    AbuMadighem, Ali
    Lunenfeld, Eitan
    Kapelushnik, Joseph
    Shi, QingHua
    Pinkas, Haim
    Huleihel, Mahmoud
    [J]. STEM CELLS AND DEVELOPMENT, 2018, 27 (15) : 1007 - 1020
  • [2] [Anonymous], 2017, CODE PRACTICE HFEA
  • [3] Defects in Androgen Biosynthesis Causing 46,XY Disorders of Sexual Development
    Auchus, Richard J.
    Miller, Walter L.
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2012, 30 (05) : 417 - 426
  • [4] Testicular tissue cryopreservation in boys. Ethical and legal issues
    Bahadur, G
    Chatterjee, R
    Ralph, D
    [J]. HUMAN REPRODUCTION, 2000, 15 (06) : 1416 - 1420
  • [5] FAMILIAL MALE PSEUDOHERMAPHRODITISM WITH GYNECOMASTIA DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE-DEFICIENCY - A REPORT OF 3 CASES
    BALDUCCI, R
    TOSCANO, V
    WRIGHT, F
    BOZZOLAN, F
    DIPIERO, G
    MARODER, M
    PANEI, P
    SCIARRA, F
    BOSCHERINI, B
    [J]. CLINICAL ENDOCRINOLOGY, 1985, 23 (04) : 439 - 444
  • [6] Batch JA, 1992, REPRODUCTIVE MED REV, V1, P131
  • [7] Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic
    Berra, Marta
    Williams, Emma L.
    Muroni, Barbara
    Creighton, Sarah M.
    Honour, John W.
    Rumsby, Gill
    Conway, Gerard S.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (06) : 1019 - 1025
  • [8] DIHYDROTESTOSTERONE REGULATION OF SEMEN IN MALE PSEUDOHERMAPHRODITES WITH 5-ALPHA-REDUCTASE-2 DEFICIENCY
    CAI, LQ
    FRATIANNI, CM
    GAUTIER, T
    IMPERATOMCGINLEY, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) : 409 - 414
  • [9] RENEWAL OF SPERMATOGONIA IN MAN
    CLERMONT, Y
    [J]. AMERICAN JOURNAL OF ANATOMY, 1966, 118 (02): : 509 - &
  • [10] Gender change in 46,XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency
    Cohen-Kettenis, PT
    [J]. ARCHIVES OF SEXUAL BEHAVIOR, 2005, 34 (04) : 399 - 410